Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973153 · ClinicalTrials.gov registry record · NA
The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up Healthy
A NA study, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT01973153: Completed NA study, sponsored by Connecticut Children's Medical Center.
NCT01973153 is a NA study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 81 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01973153, a NA study, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
Leading medical organizations have called on primary care pediatricians to take a central role in the prevention of childhood obesity. Weight counseling typically has not been incorporated into routine pediatric practice due to time and training constraints. Brief interventions with simple behavior change messages are needed to reach high-risk children, particularly Latino and Black children who are disproportionately affected by obesity and related comorbidities. Steps to Growing Up Healthy (Added Value) is a randomized controlled trial testing the efficacy of brief motivational counseling (BMC) delivered by primary care clinicians and the added value of supplementing BMC with monthly contact by community health workers (CHW) in the prevention/reversal of obesity in Latino and Black children ages 2-4 years old. Mother-child dyads (targeted n=150) are recruited for this 12-month randomized trial at an inner-city pediatric primary care clinic and randomized to: 1) BMC delivered by clinicians and nurses at well, sick, and WIC visits with the goal of reducing obesogenic behaviors (BMC); 2) BMC plus monthly phone calls by a CHW (BMC+Phone); or 3) BMC plus monthly home visits by a CHW (BMC+Home). During BMC, the medical team facilitates the selection of a specific goal (i.e., reduce sugar sweetened beverage consumption) that is meaningful to the mother and teaches the mother simple behavioral strategies. Monthly contacts with CHWs are designed to identify and overcome barriers to goal progress. Dyads are assessed at baseline and 12 months and the primary outcome is change in the child's BMI percentile. We hypothesize that BMC+Phone and BMC+Home will produce greater reductions in BMI percentiles than BMC alone and that BMC+Home will produce greater reductions in BMI percentiles than BMC+Phone.
Primary Outcome
BMI Percentile calculated using the 2000 revised CDC/NCH growth charts for the United States
Interventions
- BEHAVIORAL Brief Motivational Counseling (BMC)
- BEHAVIORAL Brief Motivational Counseling Plus Phone Calls (BMC + Phone)
- BEHAVIORAL Brief Motivational Counseling Plus Home Visits (BMC + Home)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01973153 record still lists
NCT01973153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Brief Motivational Counseling (BMC) is the first listed.
NCT01973153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01973153 about?
NCT01973153 is a clinical study titled "The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up Healthy". Leading medical organizations have called on primary care pediatricians to take a central role in the prevention of childhood obesity. Weight counseling typically has not been incorporated into routine pediatric practice due to time and training constraints. Brief interventions with simple behavior ...
What is the current status of trial NCT01973153?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2012-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01973153?
The interventions under investigation include: Brief Motivational Counseling (BMC) (BEHAVIORAL), Brief Motivational Counseling Plus Phone Calls (BMC + Phone) (BEHAVIORAL), Brief Motivational Counseling Plus Home Visits (BMC + Home) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01973153?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01973153's enrollment target sits among peer trials
81 992nd of 2000 higher than 1,007 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia